Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosisStephanie Herman, Kim Kultima, Payam Emami Khoonsari et al.|Theranostics|2018Cited by 67
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple SclerosisStephanie Herman, Kim Kultima, Torbjörn Åkerfeldt et al.|Cells|2019Cited by 66
Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjectsStephanie Herman, Kim Kultima, Valter Niemelä et al.|Scientific Reports|2019Cited by 56
Container-based bioinformatics with PachydermJon Ander Novella, Ola Spjuth, Payam Emami Khoonsari et al.|Bioinformatics|2018Cited by 55
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple SclerosisTomáš Kalinčík, John A. Snowden, Sifat Sharmin et al.|JAMA Neurology|2023Cited by 55